Skip to main content
OpenTrials
Completed

NCT Number: NCT00925444

Staple-line Reinforcement for Prevention of Pulmonary Air Leakage

The aim of this study is to compare the efficacy of FORESEAL with stapling alone or associated with tissue sealant or glue in terms of air leakage duration after lung resection for cancer.

Hypothesis: to show a significant difference of 1 day in the average duration of air leakage between the 2 groups with a standard deviation of 3 (α =0.05 and β=0.10).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Assistance Publique Hopitaux de Paris

Paris, 75000, France

About this study

Air leaks continue to be the most common complication after pulmonary resection even using a stapling device. Double chest tubes after lobectomy is a well established method for drainage of the pleural cavity to allow adequate expansion of the remaining lung.

FORESEAL has been developed to reduce air leaks by buttressing the staple line. It is a absorbable vegetal biopolymer in the form of sleeves, CE marked and indicated for prevention of air leakage after pulmonary resection with stapling device. It acts as a suture reinforcement as well as a sealant thanks to its jellification.

Sealants are also commonly used in addition to stapling to prevent air leakage. The aim of this study is to compare the efficacy of FORESEAL with stapling alone or associated with sealants.

This is a multi centre, prospective controlled and randomised clinical study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient 18 years old or over.
  • Patient that undergoes a lobectomy or bilobectomy for lung cancer,
  • Patient presenting an incomplete fissure, requiring stapling of at least 50% of the fissure and/or an emphysematous lung at the fissure point, requiring stapling.
  • Patient that has signed the informed consent before the operation.
  • Patient that benefits from a social security regime.

Exclusion criteria

  • Patient with history of thoracotomy on the side operated on.
  • Patient with severe pleural infection and/or infection of parenchyma.
  • Presence of air leakage after liberation of lung in cases of pleural symphysis.
  • Patient pregnant, giving birth or nursing.
  • Patient presenting a contra indication to the aerostatic products used.
  • Patient already participating in biomedical research.

Treatment and study plan

FOREseal

Device

a pair of alginate sleeves for linear cutting staplers used in lung surgery

Stapling

Device

Stapling alon or associated with sealants

Primary outcomes

  1. Air leak (presence or absence of bubbles) will be assessed from T0: one hour after extubation, and then twice daily (morning and evening). The mean duration of post-operative air leakage will be calculated from T0 to the last day air leak observed.

    Time frame: from T0 to the last day air leak observed

Secondary outcomes

  1. Incidence of patients presenting prolonged air leakage (lasting more than 5 days). Average duration of drainage Incidence of patients without any air leakage at 24 hours after surgery Post-operative complications Nature and costs of treatments

    Time frame: withing the first one year after surgery

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Medical and Economic Evaluation of FORESEAL Versus the Current Therapeutic Approach (Stapling Alone or Associated With Tissue Sealant) in Terms of Air Leakage Duration After Lung Resection for Cancer.

Acronym: SPIRAL

Important dates

Study start
2009
Primary completion
2013
Study completion
2013
First posted
Jun 22, 2009
Registry last updated
Sep 18, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.